Response to oxaliplatin with cetuximab in minor salivary gland adenoid cystic carcinoma

Tumori

Volumn 95, Issue 3, 2009, Pages 378-381

  De Dosso, Sara ^a   Mazzucchelli, Luca ^b   Ghielmini, Michele ^a   Saletti, Piercarlo ^a  

^a ONCOLOGY INSTITUTE OF SOUTHERN SWITZERLAND   (Switzerland)

^b INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

Adenoid cystic carcinoma; Cetuximab; Esophagus; Oxaliplatin

Indexed keywords

CETUXIMAB; CISPLATIN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADENOID CYSTIC CARCINOMA; ADULT; ARTICLE; CANCER GROWTH; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; ENDOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LABORATORY TEST; MALE; METASTASIS; MULTIPLE CYCLE TREATMENT; SALIVARY GLAND CARCINOMA; THORAX RADIOGRAPHY; ULTRASOUND;

ADENOID CYSTIC CARCINOMATA; CETUXIMAB; ESOPHAGUS; OXALIPLATIN; SALIVARY GLANDS; SQUAMOUS CELL CARCINOMA; SYSTEMIC THERAPY; TUMOR STAGING;

CHEMOTHERAPY; DISEASE CONTROL;

DIAGNOSIS;

EID: 67849086587     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160909500319     Document Type: Article

References (16)

1. Lieberman MD, Franceschi D, Marsan B, Burt M: Esophageal carcinoma, the unusual variants. J Thorac Cardiovasc Surg, 108: 1138-1146, 1994.
2. Lin YK, Wang LS, Fang HJ, Tu CW, Wu YC, Huang MH: Primary uncommon malignant tumors of the esophagus: An analysis of 30 cases. Zhonghua Yi Xue Za Zhi (Taipei), 55: 463-471, 1995.
3. Morisaki Y, Yoshizumi Y, Hiroyasu S, Shibata H, Terahata S, Tamai S, Sugiura Y, Shima S, Tanaka S: Adenoid cystic carcinoma of the esophagus: report of a case and review of the Japanese literature. Surg Today, 26:1006-1009, 1996. (Pubitemid 27065786)
4. Laurie SA, Licitra L: Systemic therapy in the palliative management of advanced salivary gland cancers. J Clin Oncol, 24: 2673-2678, 2006.
5. Matsumoto M, Nomiyama T, Nakae J, Nishikawa H: Combination chemotherapy for a senile patient with adenoid cystic carcinoma of the esophagus: a case report. Jpn J Clin Oncol, 23: 258-262, 1993.
6. Wobbes T, Wagener DJ, Schillings PH: Tumores rari et inusitati. Adenoid cystic carcinoma of the oesophagus: report of a case not responding to combination chemotherapy. Clin Oncol, 10: 261-266, 1984.
7. Petursson SR: Adenoid cystic carcinoma of the esophagus. Complete response to combination chemotherapy. Cancer, 57: 1464-1467, 1986.
8. Saletti P, Cavalli F: Metastatic colorectal cancer. Cancer Treat Rev, 32: 557-571, 2006.
9. Venook A, Niedzwiecki D, Hollis D, Sutherland S, Goldberg R, Alberts S, Benson A, Wade J, Schilsky R, Mayer R: Phase III study of irinotecan/5FU/LV (FOLFIRI) or oxaliplatin/5FU/LV (FOLFOX) +/- Cetuximab for patients (pts) with untreated metastatic adenocarcinoma of the colon or rectum (MCRC): CALGB 80203 preliminary results. Proc Am Soc Clin Oncol, abstr 3509, 2006.
10. Valverde CM, Macarulla T, Casado, Ramos FJ, Martinelli E, Tabernero J: Novel targets in gastric and esophageal cancer. Crit Rev Oncol Hematol, 59: 128-138, 2006. (Pubitemid 44094108)
11. Pinto C, Di Fabio F, Siena S, Cascinu S, Rojas Llimpe FL, Ceccarelli C Mutri V, Giannetta L, Giaquinta S, Funaioli C, Berardi R, Longobardi C, Piana E, Martoni AA: Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study). Ann Oncol, 18: 510-517, 2007.
12. Agulnik M, Cohen EW, Cohen RB, Chen EX, Vokes EE, Hotte SJ, Winquist E, Laurie S, Hayes DN, Dancey JE, Brown S, Pond GR, Lorimer I, Daneshmand M, Ho J, Tsao MS, Siu LL: A phase II study of lapatinib in recurrent or metastatic EGFR and/or Erb2 expressing adenoid cystic and non-adenoid cystic malignant tumors of the salivary glands. J Clin Oncol, 25: 3978-3984, 2007. (Pubitemid 47477277)
13. Licitra LF, Locati LD, Potepan P, Crippa F, Bossi P, Bergamini C, Rinaldi G, Liberatoscioli C, Perrone F, Losa M, Pilotti S: Cetuximab (C225) in recurrent and/or metastatic salivary gland carcinomas (RMSGCs): A monoinstitutional phase II study. Proc Am Soc Clin Oncol, abstr 5547, 2006.
14. Stordal B, Pavlakis N, Davey R: Oxaliplatin for the treatment of cisplatin-resistant cancer: a systematic review. Cancer Treat Rev, 33: 347-357, 2007. (Pubitemid 46760527)
15. Kim DY, Kim JH, Lee SH, Kim TY, Heo DS, Bang YJ, Kim NK: Phase II study of oxaliplatin, 5-fluorouracil and leucovorin in previously platinum-treated patients with advanced gastric cancer. Ann Oncol, 14: 383-387, 2003. (Pubitemid 36367414)
16. Schmid KE, Kornek GV, Schull B, Raderer M, Lenauer A, Depisch D, Lang F, Scheithauer W: Second-line treatment of advanced gastric cancer with oxaliplatin and raltitrexed. Onkologie, 26: 255-258, 2003. (Pubitemid 36831214)